Renalytix Net Debt vs Long Term Debt Analysis

RNLX Stock

USD 0.44 0.08 15.38%

Renalytix financial indicator trend analysis is much more than just breaking down Renalytix AI prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Renalytix AI is a good investment. Please check the relationship between Renalytix Net Debt and its Long Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Net Debt vs Long Term Debt

Net Debt vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Renalytix AI Net Debt account and Long Term Debt. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Renalytix's Net Debt and Long Term Debt is -0.2. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Renalytix AI, assuming nothing else is changed. The correlation between historical values of Renalytix's Net Debt and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Renalytix AI are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Net Debt i.e., Renalytix's Net Debt and Long Term Debt go up and down completely randomly.

Correlation Coefficient

-0.2

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Long Term Debt

Long-term debt is a debt that Renalytix AI has held for over one year. Long-term debt appears on Renalytix AI balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Renalytix AI balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Renalytix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Renalytix's Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to rise to about 52 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 6.03 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	58.3M	43.1M	49.5M	33.5M
Cost Of Revenue	2.1M	2.7M	3.1M	3.3M

Total Operating Expenses Cost Of Revenue

Renalytix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Other Current Liab	Property Plant And Equipment Net	Accounts Payable	Non Currrent Assets Other	Short Term Investments
Total Assets		0.52	0.68	0.96	0.89	-0.92	-0.39	0.98	0.98	0.89	0.87	-0.73	0.54	0.75	0.64	0.99	0.51	0.98	0.96	0.52	0.82	0.68	0.89	0.45	0.14	0.78
Short Long Term Debt Total	0.52		0.96	0.3	0.11	-0.22	-0.94	0.53	0.5	0.69	0.67	-0.48	0.99	0.92	0.98	0.51	1.0	0.52	0.37	1.0	0.81	0.08	0.66	0.88	0.61	0.03
Total Current Liabilities	0.68	0.96		0.48	0.29	-0.4	-0.9	0.68	0.65	0.79	0.76	-0.56	0.96	0.98	1.0	0.66	0.96	0.67	0.53	0.96	0.89	0.14	0.72	0.93	0.41	0.23
Total Stockholder Equity	0.96	0.3	0.48		0.95	-0.96	-0.16	0.94	0.94	0.77	0.75	-0.71	0.33	0.58	0.43	0.96	0.28	0.94	0.98	0.3	0.64	0.73	0.81	0.25	-0.03	0.86
Net Tangible Assets	0.89	0.11	0.29	0.95		-0.99	0.01	0.9	0.91	0.74	0.6	-0.49	0.12	0.4	0.24	0.87	0.1	0.9	0.96	0.11	0.49	0.86	0.77	0.02	-0.09	0.94
Net Debt	-0.92	-0.22	-0.4	-0.96	-0.99		0.12	-0.94	-0.95	-0.82	-0.65	0.51	-0.23	-0.51	-0.35	-0.9	-0.21	-0.95	-0.98	-0.22	-0.57	-0.85	-0.81	-0.13	0.07	-0.95
Retained Earnings	-0.39	-0.94	-0.9	-0.16	0.01	0.12		-0.42	-0.4	-0.64	-0.54	0.33	-0.91	-0.89	-0.91	-0.36	-0.94	-0.41	-0.23	-0.94	-0.73	0.05	-0.49	-0.89	-0.43	0.01
Cash	0.98	0.53	0.68	0.94	0.9	-0.94	-0.42		1.0	0.94	0.79	-0.61	0.53	0.76	0.64	0.95	0.52	1.0	0.97	0.53	0.77	0.75	0.92	0.42	0.13	0.84
Cash And Short Term Investments	0.98	0.5	0.65	0.94	0.91	-0.95	-0.4	1.0		0.94	0.77	-0.59	0.5	0.74	0.61	0.95	0.49	1.0	0.98	0.5	0.75	0.76	0.91	0.4	0.1	0.86
Net Receivables	0.89	0.69	0.79	0.77	0.74	-0.82	-0.64	0.94	0.94		0.76	-0.47	0.67	0.85	0.76	0.84	0.68	0.94	0.85	0.68	0.84	0.64	0.89	0.57	0.21	0.72
Common Stock Total Equity	0.87	0.67	0.76	0.75	0.6	-0.65	-0.54	0.79	0.77	0.76		-0.87	0.71	0.79	0.75	0.9	0.65	0.79	0.71	0.66	0.96	0.35	0.74	0.62	0.33	0.42
Common Stock Shares Outstanding	-0.73	-0.48	-0.56	-0.71	-0.49	0.51	0.33	-0.61	-0.59	-0.47	-0.87		-0.53	-0.61	-0.55	-0.8	-0.45	-0.61	-0.6	-0.47	-0.73	-0.22	-0.55	-0.46	-0.24	-0.28
Non Current Liabilities Total	0.54	0.99	0.96	0.33	0.12	-0.23	-0.91	0.53	0.5	0.67	0.71	-0.53		0.91	0.98	0.54	0.99	0.53	0.38	0.99	0.83	0.07	0.67	0.89	0.63	0.02
Other Stockholder Equity	0.75	0.92	0.98	0.58	0.4	-0.51	-0.89	0.76	0.74	0.85	0.79	-0.61	0.91		0.96	0.73	0.91	0.75	0.62	0.92	0.9	0.25	0.76	0.87	0.34	0.36
Total Liab	0.64	0.98	1.0	0.43	0.24	-0.35	-0.91	0.64	0.61	0.76	0.75	-0.55	0.98	0.96		0.62	0.98	0.63	0.48	0.98	0.88	0.12	0.71	0.92	0.49	0.16
Net Invested Capital	0.99	0.51	0.66	0.96	0.87	-0.9	-0.36	0.95	0.95	0.84	0.9	-0.8	0.54	0.73	0.62		0.49	0.96	0.94	0.5	0.82	0.63	0.86	0.45	0.13	0.74
Short Long Term Debt	0.51	1.0	0.96	0.28	0.1	-0.21	-0.94	0.52	0.49	0.68	0.65	-0.45	0.99	0.91	0.98	0.49		0.51	0.35	1.0	0.79	0.08	0.66	0.88	0.62	0.02
Total Current Assets	0.98	0.52	0.67	0.94	0.9	-0.95	-0.41	1.0	1.0	0.94	0.79	-0.61	0.53	0.75	0.63	0.96	0.51		0.98	0.52	0.77	0.75	0.92	0.42	0.13	0.84
Net Working Capital	0.96	0.37	0.53	0.98	0.96	-0.98	-0.23	0.97	0.98	0.85	0.71	-0.6	0.38	0.62	0.48	0.94	0.35	0.98		0.36	0.64	0.81	0.89	0.26	0.05	0.89
Short Term Debt	0.52	1.0	0.96	0.3	0.11	-0.22	-0.94	0.53	0.5	0.68	0.66	-0.47	0.99	0.92	0.98	0.5	1.0	0.52	0.36		0.8	0.08	0.66	0.88	0.61	0.03
Common Stock	0.82	0.81	0.89	0.64	0.49	-0.57	-0.73	0.77	0.75	0.84	0.96	-0.73	0.83	0.9	0.88	0.82	0.79	0.77	0.64	0.8		0.27	0.73	0.78	0.34	0.37
Other Current Liab	0.68	0.08	0.14	0.73	0.86	-0.85	0.05	0.75	0.76	0.64	0.35	-0.22	0.07	0.25	0.12	0.63	0.08	0.75	0.81	0.08	0.27		0.77	-0.22	0.18	0.81
Property Plant And Equipment Net	0.89	0.66	0.72	0.81	0.77	-0.81	-0.49	0.92	0.91	0.89	0.74	-0.55	0.67	0.76	0.71	0.86	0.66	0.92	0.89	0.66	0.73	0.77		0.42	0.47	0.65
Accounts Payable	0.45	0.88	0.93	0.25	0.02	-0.13	-0.89	0.42	0.4	0.57	0.62	-0.46	0.89	0.87	0.92	0.45	0.88	0.42	0.26	0.88	0.78	-0.22	0.42		0.24	0.0
Non Currrent Assets Other	0.14	0.61	0.41	-0.03	-0.09	0.07	-0.43	0.13	0.1	0.21	0.33	-0.24	0.63	0.34	0.49	0.13	0.62	0.13	0.05	0.61	0.34	0.18	0.47	0.24		-0.31
Short Term Investments	0.78	0.03	0.23	0.86	0.94	-0.95	0.01	0.84	0.86	0.72	0.42	-0.28	0.02	0.36	0.16	0.74	0.02	0.84	0.89	0.03	0.37	0.81	0.65	0.0	-0.31

Click cells to compare fundamentals

Renalytix Account Relationship Matchups

Renalytix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	41.3M	102.6M	63.3M	42.1M	48.4M	51.0M
Total Current Liabilities	3.4M	7.3M	12.2M	16.1M	18.6M	19.5M
Total Stockholder Equity	36.0M	95.1M	43.2M	18.5M	21.2M	40.5M
Net Tangible Assets	18.8M	71.5M	30.6M	7.0M	8.0M	7.6M
Net Debt	(12.7M)	(64.8M)	(28.6M)	(12.5M)	(11.3M)	(11.8M)
Retained Earnings	34.9M	3.8M	(53.0M)	(99.2M)	(89.3M)	(84.8M)
Cash	13.3M	65.2M	41.3M	24.7M	28.4M	28.2M
Non Current Assets Total	22.4M	26.6M	15.8M	13.8M	15.9M	18.0M
Cash And Short Term Investments	14.3M	74.5M	44.1M	26.1M	30.1M	30.9M
Net Receivables	18K	1.2M	901K	776K	892.4K	536.5K
Common Stock Shares Outstanding	29.5M	35.7M	36.4M	41.1M	37.0M	29.1M
Liabilities And Stockholders Equity	41.3M	102.6M	63.3M	42.1M	48.4M	51.0M
Non Current Liabilities Total	2.0M	213K	7.9M	7.5M	8.7M	9.1M
Other Stockholder Equity	2.8M	82.8M	95.9M	118.8M	136.6M	143.4M
Total Liab	5.3M	7.5M	20.1M	23.7M	27.2M	28.6M
Net Invested Capital	36.2M	71.5M	42.9M	30.4M	35.0M	38.4M
Short Long Term Debt	121K	53K	4.7M	4.5M	5.1M	5.4M
Total Current Assets	18.9M	76.0M	47.4M	28.3M	32.6M	33.0M
Net Working Capital	15.5M	59.7M	33.0M	12.2M	14.0M	23.7M
Common Stock	192K	233K	241K	299K	343.9K	221.8K
Other Current Liab	271K	5.2M	4.9M	10K	11.5K	10.9K
Property Plant And Equipment Net	945K	2.5M	3.1M	1.2M	1.4M	1.8M
Accounts Payable	2.9M	1.8M	2.5M	11.5M	13.2M	13.9M
Non Currrent Assets Other	83K	(1.1M)	1.5M	51K	58.7K	49.7K
Other Assets	2.4M	7.2M	1.2M	1.1M	1.3M	1.2M
Short Term Investments	982K	9.3M	2.7M	1.5M	1.7M	1.6M
Inventory	326K	353K	1.2M	718K	825.7K	562.5K
Other Current Assets	4.3M	(1K)	2.2M	566K	509.4K	483.9K
Property Plant And Equipment Gross	945K	2.7M	3.6M	1.2M	1.4M	1.9M
Accumulated Other Comprehensive Income	(1.9M)	8.3M	(915K)	(1.5M)	(1.3M)	(1.2M)
Capital Stock	192K	233K	228K	299K	343.9K	247.9K
Property Plant Equipment	945K	2.5M	2.6M	1.2M	1.4M	1.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
BAC	Bank of America
DD	Dupont De Nemours

When determining whether Renalytix AI offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Renalytix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Renalytix Ai Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Renalytix Ai Stock:

How To Invest In Renalytix

Details

Is Renalytix Stock a good investment?

Details

What is Renalytix's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Renalytix Stock analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is Renalytix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renalytix. If investors know Renalytix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renalytix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.76)

Revenue Per Share

0.052

Quarterly Revenue Growth

(0.41)

Return On Assets

(0.88)

Return On Equity

(6.51)

The market value of Renalytix AI is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix's value that differs from its market value or its book value, called intrinsic value, which is Renalytix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix's market value can be influenced by many factors that don't directly affect Renalytix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Renalytix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Renalytix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Renalytix Net Debt vs Long Term Debt Analysis

Net Debt vs Long Term Debt

Net Debt vs Long Term Debt Correlation Analysis

Correlation Coefficient

Net Debt

Long Term Debt

Renalytix fundamental ratios Correlations

Renalytix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Renalytix fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Renalytix Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt	+ 1.0	Short Long Term Debt Total
Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Net Debt	- 0.99	Net Tangible Assets
Net Working Capital	- 0.98	Net Debt
Net Debt	- 0.96	Total Stockholder Equity
Short Term Investments	- 0.95	Net Debt
Total Current Assets	- 0.95	Net Debt
Cash And Short Term Investments	- 0.95	Net Debt